Pharmacological Reviews, Vol. 57, No. 1. (1 March 2005), pp. 1-26.
Neuropsychopharmacology, Vol. 20, No. 4. (April 1999), pp. 322-339.
by RD
Rogers, BJ
Everitt, A
Baldacchino, AJ
Blackshaw, R
Swainson, K
Wynne, NB
Baker, J
Hunter, T
Carthy, E
Booker, M
London, JF
Deakin, BJ
Sahakian, TW
Robbins
CNS Drugs, Vol. 21, No. 3. (2007), pp. 213-237.
Harvard Review of Psychiatry, Vol. 13, No. 4. (August 2005), pp. 218-232.
Drug Alcohol Depend, Vol. 87, No. 1. (23 February 2007), pp. 1-9.
J Pharmacol Exp Ther (16 August 2007)
Proc Natl Acad Sci U S A (31 August 2007)
J Psychopharmacol (22 August 2007)
Psychopharmacology, Vol. 191, No. 4. (May 2007), pp. 985-993.
Physiol Behav (28 July 2007)
Neuropsychopharmacology, Vol. aop, No. current.
Psychopharmacology (Berl), Vol. 168, No. 1-2. (July 2003), pp. 3-20.
Biol Psychiatry (23 August 2007)
PLoS Biol, Vol. 3, No. 12. (15 November 2005)
Anesth Analg, Vol. 107, No. 1. (1 July 2008), pp. 83-95.
Br. J. Anaesth., Vol. 100, No. 6. (1 June 2008), pp. 747-758.
J. Neurosci., Vol. 28, No. 8. (20 February 2008), pp. 1824-1832.
Proc Natl Acad Sci U S A, Vol. 102, No. 8. (22 February 2005), pp. 3034-3039.
Proc Natl Acad Sci U S A, Vol. 102, No. 8. (22 February 2005), pp. 3093-3098.
by MM
Ibrahim, F
Porreca, J
Lai, PJ
Albrecht, FL
Rice, A
Khodorova, G
Davar, A
Makriyannis, TW
Vanderah, HP
Mata, TP
Malan
Am J Physiol Heart Circ Physiol (19 October 2007)
BMJ, Vol. 332, No. 7537. (11 February 2006), pp. 345-346.
BMJ, Vol. 332, No. 7539. (25 February 2006), pp. 488-489.
Annu Rev Pharmacol Toxicol, Vol. 44 (2004), pp. 269-296.
AAPS J, Vol. 7, No. 2. (2005)
Clin Diabetes, Vol. 23, No. 1. (1 January 2005), pp. 9-15.